WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 2'5501 Infant (under 12 months) mortality rate: 642
GDP / capita (US$): 4'4261 Child (under 5 years) mortality rate: 992

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 4'337  4'225  4'112  3'995  3'876  3'126  2'383  1'796 
Births 165  162  159  155  152  122  91  76 
Surviving infants 154  151  148  144  141  112  84  70 
Pop. less than 5 years 722  703  682  664  644  514  394  321 
Pop. less than 15 years 1'842  1'791  1'736  1'689  1'638  1'310  1'041  804 
Female 15-49 years 1'024  1'001  977  949  920  744  541  395 

Number of reported case

(Click for retrospective incidence data for Congo (the))
Diphtheria
Japanese encephalitis
Measles 260  315  1'678  3'608  11'892 
Mumps
Pertussis 12  52  11'198 
Polio* 380  47  136 
Rubella 22  10  11  21 
Rubella (CRS)
Tetanus (neonatal) 18  80 
Tetanus (total) 27  167 
Yellow fever 188 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Congo (the))
Vaccine year result method % card seen                                                
BCG 2010  94  DHS   57.2  92  95  95  90  93  50  86 
DTP1 2010  89  DHS   57.2  90  90  90  93  93 
DTP3 2010  72  DHS   57.2  85  90  90  91  89  33  77 
HepB_BD         
HepB3 2009  67  EPI   88.0  85  90  90  91  89 
Hib3 2009  67  EPI   88.0  85  90  90  91 
JapEnc         
MCV 2010  75  DHS   57.2  80  90  90  76  79  34  77 
MCV2         
PCV1          50 
PCV3          10 
Pol3 2010  57  DHS   57.2  85  90  90  91  89  94 
Rota1         
Rota_last         
Rubella1         
TT2plus 1989  60  EPI     85  92  92  91  93  39  52 
PAB         
VAD1          77  90  90  86  23 
YFV 2009  63  EPI   88.0  80  90  90  77  74 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Congo (the))
BCG 92  95  95  90  93  50  90  92 
DTP1 90  90  90  92  93  45  92  67 
DTP3 85  90  90  91  89  33  79  42 
HepB3 85  90  90  91  89 
Hib3 85  90  90  91 
MCV 80  90  90  76  79  34  75  49 
PAB 83  83  83  82  82  67  60 
PCV3 10 
Pol3 85  90  90  91  89  31  80  42 
Rota_last
YFV 80  90  90  77  74 

Number of districts in the country 30  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 27
From 80 to 89% 43
From 50 to 79% 27
Less than 50% 3
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHep 8, 12, 16 weeks; Yes
Measles 36 weeks; Yes
OPV birth; 8, 12, 16 weeks; Yes
Pneumo_conj 8, 12, 16 weeks; Yes
Rotavirus Yes From March 2014
TT 1st contact pregnancy; +4 weeks; Yes
VitaminA 36 weeks; Yes
YF 36 weeks; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2011-2015  2008-2011  2008-2011  2008-2011  2008 à 2011  2004-2008 
Nº of districts with microplans that include activities to raise immunization coverage number 30  30  30  30  27  27  27 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number 30  30  30  30  27  27  27 
Nº districts with DTP3 coverage >=80% number 21  22  19  24  24  17  12 
% of districts with DTP3 coverage >=80% From 0 to 100% 70  73  63  80  89  63  44 
Nº districts with measles (MCV1) coverage >=95% number    
% of districts with MCV1 coverage >=95% From 0 to 100% 13  23  13     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR No  No  No  No  No  No  No 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  No  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 11  NA  100  100  100  75 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  No  No  No 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.